Sleep Apnea and Preeclampsia: A Pregnancy Risk Too Often Overlooked
Sleep Apnea and Preeclampsia: The Overlooked Link Every Expectant Mother Should Know
Loud snoring in pregnancy can signal more than a restless night — emerging European evidence ties sleep-disordered breathing to a measurable rise in preeclampsia risk.
The Hidden Connection Between Sleep Apnea and Preeclampsia
The link between sleep apnea and preeclampsia is real, measurable, and largely under-recognised across Europe. Obstructive sleep apnea (OSA) is a condition where the upper airway collapses during sleep, briefly stopping breathing. Preeclampsia is a pregnancy disorder marked by high blood pressure and organ stress, usually after 20 weeks. A growing body of research now shows that maternal OSA is an independent risk factor for preeclampsia, not merely a coincidence.
This matters because most European antenatal pathways do not routinely screen for OSA. Expectant mothers in France, Germany, the UK, Spain, and Italy are rarely asked about snoring or breathing pauses. As a result, maternal sleep-disordered breathing is systematically under-diagnosed. If you have noticed new snoring or daytime exhaustion, it is worth understanding the full picture of sleep apnea risks for mother and baby before dismissing it as normal tiredness.
Preeclampsia affects roughly 2-5% of pregnancies in Western Europe — about 1 in 25 in the UK — according to WHO and European incidence data summarised through 2025. Hypertensive disorders, including preeclampsia, account for around 16% of maternal deaths worldwide. These are not rare events, and a modifiable contributor like sleep apnea deserves attention.
- Maternal sleep apnea is an independent risk factor for preeclampsia, not a coincidence.
- Most EU antenatal pathways do not routinely screen for OSA, so it is often missed.
- New snoring or daytime exhaustion in pregnancy deserves a conversation with your provider.
How Sleep Apnea Drives Preeclampsia Risk
Sleep apnea raises preeclampsia risk through a chain of biological events triggered by repeated drops in oxygen at night. Each time the airway collapses, oxygen levels fall and then rebound when breathing restarts. This cycle of intermittent nocturnal hypoxia (low oxygen) stresses the body in ways that directly affect the placenta and blood vessels.
Peer-reviewed reviews describe the mechanism clearly. Repeated oxygen swings cause oxidative stress (cell damage from unstable oxygen molecules), sympathetic activation (a fight-or-flight surge that raises blood pressure), systemic inflammation, and endothelial dysfunction (damage to the lining of blood vessels). Together these impair placental oxygenation, which is the same pathway that produces preeclampsia symptoms.
The snoring-to-hypertension chain
The progression often starts quietly. Loud snoring signals a narrowing airway. That narrowing leads to brief breathing pauses and oxygen dips. The body responds with stress hormones and rising blood pressure, setting the stage for the hypertensive disorders that define preeclampsia. The same mechanism explains the broader connection between sleep apnea and high blood pressure outside of pregnancy.
- Intermittent nocturnal hypoxia triggers oxidative stress and a blood-pressure surge.
- This damages blood vessels and impairs placental oxygen delivery.
- The same placental pathway produces the symptoms doctors recognise as preeclampsia.
What the Evidence Says About Sleep Apnea and Preeclampsia
The evidence linking sleep apnea and preeclampsia has strengthened sharply over the past decade, moving from observation to interventional proof. Large pooled analyses now quantify the risk, and at least one randomised controlled trial shows that treating maternal OSA lowers preeclampsia rates.
A 2024 systematic review and meta-analysis in the Journal of Maternal-Fetal & Neonatal Medicine pooled 120 studies covering roughly 58 million pregnant women. It found maternal sleep disturbances raised preeclampsia risk with an odds ratio (OR) of 2.80, and obstructive sleep apnea specifically with an OR of 2.36. Earlier work, published on PubMed in 2018, reported an adjusted OR of 2.72 for preeclampsia-eclampsia among women at high OSA risk, supporting OSA as an independent factor.
| Study (Year) | Design | Population | Key Finding |
|---|---|---|---|
| J Matern Fetal Neonatal Med (2024) | Meta-analysis, 120 studies | ~58 million women | OSA: OR 2.36 for preeclampsia |
| PubMed PMID 30484015 (2018) | Cohort analysis | High OSA-risk women | Adjusted OR 2.72 for preeclampsia-eclampsia |
| Respiratory Research, BMC (2023) | Multicenter RCT | 310 high-risk women | CPAP cut preeclampsia to 13.1% vs 22.3% |
| PMC meta-analysis (2024) | 6 studies, 809 women | Pregnant women with OSA | CPAP: ~30% lower preeclampsia risk |
The strongest interventional signal comes from a 2023 multicenter randomised controlled trial published in Respiratory Research (BMC). Among high-risk pregnant women with predominantly mild-to-moderate OSA, preeclampsia occurred in 13.1% of those treated with CPAP versus 22.3% in usual care (risk difference about -9%, p=0.032). A separate 2024 meta-analysis of six studies found CPAP was associated with roughly a 35% reduction in gestational hypertension and a 30% reduction in preeclampsia.
- OSA roughly doubles preeclampsia odds (OR ~2.36) across 58 million women studied.
- A 2023 RCT showed CPAP cut preeclampsia from 22.3% to 13.1% in high-risk women.
- Treating maternal OSA is now considered a modifiable way to improve outcomes.
How Common Is Sleep Apnea in Pregnancy?
Obstructive sleep apnea is more common in pregnancy than many expectant mothers realise, and it tends to worsen as pregnancy advances. Hormonal shifts, weight gain, and increased blood volume all narrow the upper airway, especially in the third trimester.
A 2019 PubMed systematic review found OSA in about 3.6% of first-time mothers during the first trimester, rising to as high as ~26% near term. The same body of work reported pooled worldwide OSA prevalence ranging from about 5% in the European Region to 20% in the Americas. Among obese pregnant women, the Preeclampsia Foundation notes that roughly 1 in 5 may have sleep apnea.
Because risk climbs across trimesters, awareness should grow too. OSA is also widely missed in women generally, and our guide to why sleep apnea is missed in women and how to get diagnosed explains why symptoms that seem minor early on can intensify later in pregnancy.
- OSA prevalence rises from about 3.6% early to as high as 26% near term.
- European Region prevalence is around 5%, lower than the Americas at 20%.
- Weight gain, hormones, and blood volume narrow the airway as pregnancy progresses.
A Self-Check for Warning Signs
You can watch for several recognisable warning signs that suggest sleep-disordered breathing during pregnancy. None of these confirm OSA on their own, but together they justify asking for a proper sleep assessment. Because EU antenatal care rarely screens for snoring, self-awareness is your first line of defence.
1New or louder snoring
Snoring that begins or worsens during pregnancy is the single most reported early sign of airway narrowing.
2Witnessed breathing pauses
A partner noticing gasps, choking sounds, or silent pauses is a strong reason to seek evaluation.
3Morning headaches
Frequent headaches on waking can reflect overnight oxygen dips and disrupted sleep quality.
4Daytime exhaustion
Severe, unrefreshing tiredness beyond normal pregnancy fatigue may signal fragmented sleep.
Clinicians often use simple questionnaires such as STOP-BANG or the Berlin Questionnaire to estimate OSA risk. If your screening suggests elevated risk, a sleep study can usually be arranged safely during pregnancy, frequently as a home-based test.
- Watch for new snoring, witnessed pauses, morning headaches, and daytime exhaustion.
- STOP-BANG and Berlin questionnaires help estimate OSA risk quickly.
- Sleep studies, often at home, are generally safe during pregnancy.
The Treatment Ladder: From Snoring to Severe OSA
Treatment for sleep-disordered breathing in pregnancy follows a ladder matched to severity, and the right step depends on a proper diagnosis. Severe OSA requires medical management, while snoring and mild airway obstruction may respond to conservative measures. Understanding where you sit helps you have a focused conversation with your care team.
| Severity | Typical Approach | Evidence Level |
|---|---|---|
| Severe OSA | CPAP (continuous positive airway pressure) | RCT-supported; lowers preeclampsia risk |
| Moderate OSA | CPAP or specialist-guided therapy | Strong; gold-standard management |
| Mild OSA / snoring | Positional therapy, nasal/airway aids, weight and sleep-position advice | Conservative, first-line options |
| Back2Sleep stent | Soft silicone intranasal stent keeping the airway open | For snoring + mild-to-moderate OSA only |
CPAP is the evidence-based gold standard for moderate-to-severe OSA, and the 2023 RCT confirmed it reduces preeclampsia in high-risk pregnancies. Some women, however, find the mask and tubing hard to tolerate. For those who snore or have mild-to-moderate OSA — and only after medical evaluation — conservative options become relevant.
The Back2Sleep intranasal stent is a CE-certified Class I device made of soft silicone. It sits in the nasal passage to keep the upper airway open during sleep, reducing snoring and obstruction. It uses no electricity, no noise, and no tubing, and a starter kit includes four sizes. Importantly, it is designed for snoring and mild-to-moderate OSA, not as a treatment for severe OSA or for preeclampsia itself.
- Severe and moderate OSA need CPAP, the RCT-backed gold standard.
- Snoring and mild OSA may respond to conservative, first-line options.
- Back2Sleep addresses one modifiable link in the chain but never replaces medical care.
Why Europe Needs Better Awareness
Europe lags behind in recognising maternal sleep apnea as a preeclampsia risk factor. While some health systems have introduced sleep-screening guidance for pregnancy, most EU antenatal pathways still include no routine OSA screening. This gap means many at-risk women are never asked the simple questions that could flag a problem early.
Closing this gap does not require expensive technology — it starts with awareness. Asking your midwife about snoring, completing a STOP-BANG questionnaire if you have warning signs, and requesting a sleep assessment when appropriate are practical steps. Reducing snoring and mild airway obstruction tackles one modifiable contributor in the snoring-to-hypoxia-to-hypertension chain, while medical management handles the rest.
- Most EU antenatal care does not routinely screen for OSA.
- Awareness and simple questionnaires can flag at-risk women early.
- Tackling snoring addresses one link; medical care manages the rest.
What Back2Sleep Users Say
Frequently Asked Questions
Can sleep apnea cause preeclampsia, or are they just linked?
Research strongly suggests sleep apnea is an independent risk factor for preeclampsia, not just a coincidence. A 2023 randomised trial found that treating maternal OSA with CPAP lowered preeclampsia rates, supporting a causal contribution. The likely mechanism is repeated overnight oxygen drops that trigger inflammation, blood-pressure surges, and blood-vessel damage affecting the placenta.
How much does sleep apnea increase the risk of preeclampsia in pregnancy?
A 2024 meta-analysis of 120 studies covering roughly 58 million women found obstructive sleep apnea raised preeclampsia odds by about 2.36 times. Earlier 2018 research reported an adjusted odds ratio of 2.72 in high-risk women. In practical terms, OSA roughly doubles to triples the likelihood of developing preeclampsia during pregnancy.
Is snoring during pregnancy a sign of sleep apnea or a warning for preeclampsia?
New or louder snoring during pregnancy can signal narrowing of the airway and possible sleep apnea, which is itself linked to preeclampsia. Snoring alone does not confirm either condition. However, it is a recognised warning sign worth raising with your midwife or doctor, especially alongside breathing pauses, headaches, or swelling.
Does treating sleep apnea with CPAP lower the risk of preeclampsia?
Yes, the strongest evidence supports this. A 2023 multicenter randomised controlled trial found preeclampsia occurred in 13.1% of women using CPAP versus 22.3% in usual care. A 2024 meta-analysis reported roughly a 30% reduction in preeclampsia with CPAP. CPAP remains the gold standard for moderate-to-severe OSA in pregnancy.
How common is obstructive sleep apnea in pregnancy?
Obstructive sleep apnea affects about 3.6% of first-time mothers in early pregnancy, rising to as high as 26% near term as weight and blood volume increase. Worldwide pooled prevalence ranges from roughly 5% in the European Region to 20% in the Americas. Among obese pregnant women, about 1 in 5 may have OSA.
Can you do a sleep study while pregnant, and when should you be screened?
Yes, sleep studies are generally safe during pregnancy and are often done at home. Screening is sensible if you have warning signs like new loud snoring, witnessed breathing pauses, morning headaches, or severe daytime exhaustion. Clinicians may use STOP-BANG or Berlin questionnaires first, then arrange a formal sleep assessment if risk appears elevated.
What can I do about snoring and mild sleep apnea while pregnant if I cannot tolerate CPAP?
For snoring or mild-to-moderate OSA, and only after medical evaluation, conservative options include positional therapy, sleep-position advice, and nasal or airway aids. The Back2Sleep intranasal stent is a CE-certified device for snoring and mild-to-moderate OSA. It does not treat severe OSA or preeclampsia, so discuss any device with your obstetrician first.
Ready for quieter nights? Discover the Back2Sleep starter kit and find the right fit for you.
Not sure if you are at risk? Take our sleep risk screening to find out in just a few minutes.
Want to learn how it works? Explore the Back2Sleep nasal stent designed for comfortable, effective relief.